OUTLOOK THERAPEUTICS Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

OUTLOOK THERAPEUTICS Stock Summary

OUTLOOK THERAPEUTICS competes with Checkpoint Therapeutics, Mustang Bio, Reviva Pharmaceuticals, Fortress Biotech, and Kodiak Sciences. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Outlook Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

OUTLOOK THERAPEUTICS Key Financial Ratios

OUTLOOK THERAPEUTICS Key Balance Sheet Accounts

OUTLOOK THERAPEUTICS Key Income Statement Accounts

OUTLOOK THERAPEUTICS Key Cash Accounts

OUTLOOK Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining OUTLOOK THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare OUTLOOK THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OUTLOOK THERAPEUTICS competition to find correlations between indicators driving OUTLOOK THERAPEUTICS's intrinsic value. More Info.OUTLOOK THERAPEUTICS INC is regarded second in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, OUTLOOK THERAPEUTICS's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value OUTLOOK THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

OUTLOOK THERAPEUTICS INC Systematic Risk

Today, most investors in OUTLOOK THERAPEUTICS Stock are looking for potential investment opportunities by analyzing not only static indicators but also various OUTLOOK THERAPEUTICS's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of OUTLOOK THERAPEUTICS growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of OUTLOOK THERAPEUTICS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OUTLOOK THERAPEUTICS INC. We use our internally-developed statistical techniques to arrive at the intrinsic value of OUTLOOK THERAPEUTICS INC based on widely used predictive technical indicators. In general, we focus on analyzing OUTLOOK Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OUTLOOK THERAPEUTICS's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.